What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis?

Aydin F., ÇAKAR N., Kurt T., Acar B. C., Celikel E., Ozcakar Z. B., ...Daha Fazla

CLINICAL RHEUMATOLOGY, cilt.41, sa.12, ss.3791-3796, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 12
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s10067-022-06327-4
  • Dergi Adı: CLINICAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.3791-3796
  • Anahtar Kelimeler: Intra-articular corticosteroid injection, Juvenile idiopathic arthritis, Remission, TRIAMCINOLONE HEXACETONIDE, EFFICACY, CHILDREN, MANAGEMENT, THERAPY, PLUS
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction Intra-articular corticosteroid injection (IACI) is generally used in the management of juvenile idiopathic arthritis (JIA) to obtain rapid relief of active synovitis and functional recovery and to prevent the need for regular systemic therapy. The aim of this study was to investigate the outcome of IACI treatment and the factors associated with remission of synovitis.